{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T09:34:30Z","timestamp":1772357670764,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"DOI":"10.7759\/cureus.104465","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:02:37Z","timestamp":1772352157000},"source":"Crossref","is-referenced-by-count":0,"title":["Antiepileptic Drug-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Case Series"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Mohaideen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muthu","family":"Meera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilavendiran","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-00416-4","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): how far have we come?","volume":"20","author":"Mart\u00ednez-Cabriales SA","year":"2019","unstructured":"Mart\u00ednez-Cabriales SA, Rodr\u00edguez-Bola\u00f1os F, Shear NH. Drug reaction with eosinophilia and systemic symptoms (DRESS): how far have we come?. Am J Clin Dermatol. 2019, 20:217-36. 10.1007\/s40257-018-00416-4","journal-title":"Am J Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: a literature review and treatment algorithm","volume":"16","author":"Calle AM","year":"2023","unstructured":"Calle AM, Aguirre N, Ardila JC, Cardona Villa R. DRESS syndrome: a literature review and treatment algorithm. World Allergy Organ J. 2023, 16:100673. 10.1016\/j.waojou.2022.100673","journal-title":"World Allergy Organ J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub P","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. The DRESS syndrome: a literature review. Am J Med. 2011, 124:588-97. 10.1016\/j.amjmed.2011.01.017","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000286","article-title":"Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions","volume":"16","author":"Wang CW","year":"2016","unstructured":"Wang CW, Dao RL, Chung WH. Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions. Curr Opin Allergy Clin Immunol. 2016, 16:339-45. 10.1097\/ACI.0000000000000286","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061243","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho YT","year":"2017","unstructured":"Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017, 18:10.3390\/ijms18061243","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler WJ","year":"2003","unstructured":"Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003, 139:683-93. 10.7326\/0003-4819-139-8-200310210-00012","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update","volume":"103","author":"Phillips EJ","year":"2018","unstructured":"Phillips EJ, Sukasem C, Whirl-Carrillo M, et al.. Clinical Pharmacogenetics Implementation Consortium guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update. Clin Pharmacol Ther. 2018, 103:574-81. 10.1002\/cpt.1004","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8010-9","article-title":"A complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara T","year":"2007","unstructured":"Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007, 33:124-33. 10.1007\/s12016-007-8010-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun SH","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2007, 156:609-11. 10.1111\/j.1365-2133.2006.07704.x","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara T","year":"2007","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007, 156:1083-4. 10.1111\/j.1365-2133.2007.07807.x","journal-title":"Br J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet H","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996 , 15:250-7. 10.1016\/s1085-5629(96)80038-1","journal-title":"Semin Cutan Med Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Caba\u00f1as R","year":"2020","unstructured":"Caba\u00f1as R, Ram\u00edrez E, Sendagorta E, et al.. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol. 2020, 30:229-53. 10.18176\/jiaci.0480","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson AR","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract. 2019, 7:633-40. 10.1016\/j.jaip.2018.08.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref15","unstructured":"American Academy of Allergy, Asthma & Immunology. DRESS syndrome cases in the US: rare, morbid, and costly. (2018). Accessed: February 06, 2026: https:\/\/www.aaaai.org\/tools-for-the-public\/latest-research-summaries\/the-journal-of-allergy-and-clinical-immunology-i...."},{"key":"ref16","unstructured":"World Health Organization \u2014 Uppsala Monitoring Centre. The use of the WHO-UMC system for standardised case causality assessment. (2013). Accessed. February 06, 2026: https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028096","article-title":"Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool","volume":"6","author":"Gallagher RM","year":"2011","unstructured":"Gallagher RM, Kirkham JJ, Mason JR, et al.. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One. 2011, 6:e28096. 10.1371\/journal.pone.0028096","journal-title":"PLoS One"},{"key":"ref19","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992, 27:538.","journal-title":"Hosp Pharm"},{"key":"ref20","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig SC","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992, 49:2229-32.","journal-title":"Am J Hosp Pharm"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen YC","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010, 146:1373-9. 10.1001\/archdermatol.2010.198","journal-title":"Arch Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki M","year":"2009","unstructured":"Eshki M, Allanore L, Musette P, et al.. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009, 145:67-72. 10.1001\/archderm.145.1.67","journal-title":"Arch Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.189","article-title":"HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review","volume":"92","author":"Yip VL","year":"2012","unstructured":"Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther. 2012, 92:757-65. 10.1038\/clpt.2012.189","journal-title":"Clin Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.02.005","article-title":"Influence of chemical structure on skin reactions induced by antiepileptic drugs--the role of the aromatic ring","volume":"94","author":"Wang XQ","year":"2011","unstructured":"Wang XQ, Shi XB, Au R, Chen FS, Wang F, Lang SY. Influence of chemical structure on skin reactions induced by antiepileptic drugs--the role of the aromatic ring. Epilepsy Res. 2011, 94:213-7. 10.1016\/j.eplepsyres.2011.02.005","journal-title":"Epilepsy Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0049","article-title":"Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen","volume":"86","author":"Yun SJ","year":"2006","unstructured":"Yun SJ, Lee JB, Kim EJ, Quan G, Kim SJ, Won YH, Lee SC. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen. Acta Derm Venereol. 2006, 86:241-4. 10.2340\/00015555-0049","journal-title":"Acta Derm Venereol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.10.77","article-title":"Pharmacogenetics of drug hypersensitivity","volume":"11","author":"Phillips EJ","year":"2010","unstructured":"Phillips EJ, Mallal SA. Pharmacogenetics of drug hypersensitivity. Pharmacogenomics. 2010, 11:973-87. 10.2217\/pgs.10.77","journal-title":"Pharmacogenomics"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000335612","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"97","author":"Mockenhaupt M","year":"2012","unstructured":"Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy. 2012, 97:1-17. 10.1159\/000335612","journal-title":"Chem Immunol Allergy"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/srep05981","article-title":"Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications","volume":"4","author":"Ueta M","year":"2014","unstructured":"Ueta M, Kannabiran C, Wakamatsu TH, et al.. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications. Sci Rep. 2014, 4:5981. 10.1038\/srep05981","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465610-antiepileptic-drug-induced-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:02:39Z","timestamp":1772352159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465610-antiepileptic-drug-induced-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.104465","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}